Brief: CymaBay Reports Q4 And Year Ended Dec 31, 2021 Results
17/03/2022 20:08
March 17 (Reuters) - Cymabay Therapeutics Inc CBAY.O :
* CYMABAY REPORTS FOURTH QUARTER AND YEAR ENDED DECEMBER 31,
2021
FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
* CYMABAY THERAPEUTICS INC QTRLY LOSS PER SHARE $0.34
Source text for Eikon: ID:nGNX813s21
Further company coverage: CBAY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CymaBay Therapeutics
See all newsBrief: CymaBay Says EMA Accepted For Review The Marketing Authorization Application For Seladelpar
U.S. RESEARCH ROUNDUP-Bruker Corp, Cymabay Therapeutics, SSR Mining
U.S. RESEARCH ROUNDUP-An2 Therapeutics, Par Technology, Trimble
U.S. STOCKS ON THE MOVE-Perpetua Resources, Nvidia, SiriusXM
U.S. STOCKS ON THE MOVE-Lowe's, Bit Digital Snap